Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

Social isolation makes mice more sensitive to alcohol's effects on brain function.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

MK-386 lowers DHT in blood and skin but not in semen.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

The FDA did not approve a testosterone drug because of safety concerns.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.